[ET Net News Agency, 4 November 2026] SKB BIO (06990) rose 10.1% to HK$442.2.
It hits an intra-day high of HK$442.8, breaking above the 10-D SMA of HK$440.76, and an intra-day low of HK$396.6. The total shares traded was 907,846, with a value of HK$382.96m. The active buy/sell ratio is 68:32, with net buying turnover of HK$131.68m. CITIGROUP GLOBAL accounts for greatest net responsive buying turnover of HK$28.24m, with volume weighted average price of HK$423.176. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$47.34m, with volume weighted average price of HK$421.66.
Basic Information| Nominal | 442.200 | % Chg | +10.11% |
| High | 442.800 | Low | 396.600 |
| Shares Tr | 907,846 | Turnover | 382.96m |
| 10-D SMA | 440.760 | %H.V | 51.509 |
| 20-D SMA | 446.760 | VWAP | 421.835 |
| 50-D SMA | 468.952 | RSI14 | 47.494 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$131.68m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SKB BIO (06990) | 442.20 | +10.11 |
| GENSCRIPT B-1K (01548) | 33.68 | +11.45 |
| INNOVENT BIO (01801) | 84.45 | +6.43 |
| XTALPI (02228) | 6.06 | +3.59 |
| WUXI XDC (02268) | 71.10 | +12.15 |
| WUXI BIO (02269) | 48.22 | +11.98 |
| WUXI APPTEC (02359) | 197.40 | +12.16 |
| BEONE MEDICINES (06160) | 229.60 | +9.23 |
| AKESO (09926) | 82.15 | +6.55 |
| REMEGEN (09995) | 69.20 | +10.63 |
(ed)
Nominal 
